Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST.
Salati M, De Ruvo N, Giglio MC, Sorrentino L, Esposito G, Fenocchi S, Cucciarrè G, Serra F, Rossi EG, Vittimberga G, Radi G, Solaini L, Morgagni P, Grizzi G, Ratti M, Gelsomino F, Spallanzani A, Ghidini M, Ercolani G, Dominici M, Gelmini R. Salati M, et al. Among authors: gelsomino f. J Clin Med. 2022 Sep 16;11(18):5439. doi: 10.3390/jcm11185439. J Clin Med. 2022. PMID: 36143086 Free PMC article.
[Gastric carcinoma: an evolutionary scenario.].
Gelsomino F, Spallanzani A, De Vita F, Di Bartolomeo M, Gavazzi C, Rimassa L, Cascinu S. Gelsomino F, et al. Recenti Prog Med. 2017 Mar;108(3):120-127. doi: 10.1701/2656.27234. Recenti Prog Med. 2017. PMID: 28398405 Review. Italian.
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study).
Gelsomino F, Bertolini F, Luppi G, Spallanzani A, Pettorelli E, Reggiani Bonetti L, Meduri B, Manco G, Conte P, Cascinu S. Gelsomino F, et al. Clin Colorectal Cancer. 2017 Dec;16(4):410-415.e1. doi: 10.1016/j.clcc.2017.03.011. Epub 2017 Mar 24. Clin Colorectal Cancer. 2017. PMID: 28410832 Clinical Trial.
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study.
Campana D, Walter T, Pusceddu S, Gelsomino F, Graillot E, Prinzi N, Spallanzani A, Fiorentino M, Barritault M, Dall'Olio F, Brighi N, Biasco G. Campana D, et al. Among authors: gelsomino f. Endocrine. 2018 Jun;60(3):490-498. doi: 10.1007/s12020-017-1474-3. Epub 2017 Nov 17. Endocrine. 2018. PMID: 29150792 Free article.
Lenvatinib as a therapy for unresectable hepatocellular carcinoma.
Spallanzani A, Orsi G, Andrikou K, Gelsomino F, Rimini M, Riggi L, Cascinu S. Spallanzani A, et al. Among authors: gelsomino f. Expert Rev Anticancer Ther. 2018 Nov;18(11):1069-1076. doi: 10.1080/14737140.2018.1524297. Epub 2018 Sep 21. Expert Rev Anticancer Ther. 2018. PMID: 30220234 Review.
Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion.
Prampolini F, Taschini S, Pecchi A, Sani F, Spallanzani A, Gelsomino F, Kaleci S, Torricelli P. Prampolini F, et al. Among authors: gelsomino f. Abdom Radiol (NY). 2020 Oct;45(10):2941-2949. doi: 10.1007/s00261-018-1838-z. Abdom Radiol (NY). 2020. PMID: 30483843
206 results